Form 4: Marsh & McLennan Companies Executive Dean Michael Klisura Reports Stock Option Grant and RSU Vesting

Sentiment:

SEC Form 4 Filing


Dean Michael Klisura, President & CEO of Guy Carpenter at Marsh & McLennan Companies, reports the grant of stock options and vesting of restricted stock units.

Summary

  • Dean Michael Klisura, a key executive at Marsh & McLennan Companies, filed a Form 4 detailing changes in beneficial ownership.
  • On February 18, 2025, Klisura was granted 17,447 stock options with an exercise price of $230.29.
  • These options vest in four equal annual installments starting February 18, 2026.
  • Additionally, 9,910 restricted stock units (RSUs) vested on the same date.
  • These RSUs relate to performance stock units granted on February 23, 2022, for the performance period 2022-2024, with the performance factor determined on February 18, 2025.
  • The RSUs convert to common stock on a 1-for-1 basis.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of executive compensation. The vesting of RSUs and granting of options are generally viewed as a positive sign of alignment with company performance, but it's not a major event.

Positives

  • The vesting of RSUs and granting of stock options to a key executive suggests confidence in the company's future performance.

Industry Context

Form 4 filings are standard practice and provide transparency into executive compensation and ownership changes, which are closely monitored by investors in the financial services industry.

Comparison to Industry Standards

  • Executive compensation packages including stock options and RSUs are common in publicly traded companies like Marsh & McLennan, Aon, and Willis Towers Watson.
  • The vesting schedules and performance-based components are typical for aligning executive incentives with shareholder value.

Stakeholder Impact

  • Shareholders may view the executive compensation package as an incentive for management to drive company performance.
  • Employees may see the executive's stake in the company as a positive sign of leadership commitment.

Key Dates

DateDescription
February 23, 2022Performance stock units granted for the 2022-2024 performance period.
February 18, 2025Grant date of stock options and vesting date of restricted stock units; performance factor determined for performance stock units.
February 18, 2026First vesting date for the stock options.
February 17, 2035Expiration date for the stock options.
February 20, 2025Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.